CD163 and neoplasm: We compared proportions of CD3+, CD4+, and CD8+ T cells, CD57+ natural killer (NK) cells, CD4+ FOXP3+ regulatory T cells (Tregs), and CD68+ CD163+ M2 tumor-associated macrophages (TAMs) between paired ACC and SCCC samples, respectively.